Zusammenfassung
Bei den meisten zystischen Neoplasien des Pankreas ist aufgrund des signifikanten Malignitätsrisikos eine chirurgische Resektion des Tumors indiziert. So sollten alle muzinös-zystischen Neoplasien (MCN) und alle solid-papillären Tumoren wenn möglich reseziert werden. Zudem wird empfohlen, alle intraduktalen papillär-muzinösen Neoplasien (IPMN) vom Haupt- und Mischtyp und die meisten Seitengang-IPMN zu operieren. Lediglich kleine, asymptomatische Seitengang-IPMN von einem Durchmesser von weniger als 1,5–2 cm ohne radiologisch malignitätsverdächtige Merkmale sowie kleinere, asymptomatische serös-zystische Neoplasien können in regelmäßigen Abständen durch bildgebende Verfahren verlaufskontrolliert werden. Bei Größenprogredienz, Auftreten einer klinischen Symptomatik oder bildmorphologisch unklarer Diagnose sollten jedoch auch diese chirurgisch angegangen werden.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Correa-Gallego C, Ferrone CR, Thayer SP, Wargo JA, Warshaw AL, Fernandez-del Castillo C (2010) Incidental pancreatic cysts: do we really know what we are watching? Pancreatology 10: 144–150
Crippa S, Salvia R, Warshaw AL, Dominguez I, Bassi C, Falconi M, Thayer SP, Zamboni G, Lauwers GY, Mino-Kenudson M, Capelli P, Pederzoli P, Castillo CF (2008) Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg 247: 571–579
Fernandez-del Castillo C, Adsay NV (2010) Intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology 139: 708–713, e701–702
Fritz S, Klauss M, Bergmann F, Hackert T, Hartwig W, Strobel O, Bundy BD, Buchler MW, Werner J (2012) Small (Sendai negative) branch-duct IPMNs: not harmless. Ann Surg 256: 313–320
Fritz S, Schirren M, Klauss M, Bergmann F, Hackert T, Hartwig W, Strobel O, Grenacher L, Buchler MW, Werner J (2012) Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas. Surgery 152: 74–80
Fritz S, Warshaw AL, Thayer SP (2009) Management of mucin-producing cystic neoplasms of the pancreas. Oncologist 14: 125–136
Jang JY, Kim SW, Lee SE, Yang SH, Lee KU, Lee YJ, Kim SC, Han DJ, Choi DW, Choi SH, Heo JS, Cho BH, Yu HC, Yoon DS, Lee WJ, Lee HE, Kang GH, Lee JM (2008) Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe? Ann Surg Oncol 15: 199–205
Matsumoto T, Hirano S, Yada K, Shibata K, Sasaki A, Kamimura T, Ohta M, Kitano S, Kashima K (2005) Malignant serous cystic neoplasm of the pancreas: report of a case and review of the literature. J Clin Gastroenterol 39: 253–256
Reddy RP, Smyrk TC, Zapiach M, Levy MJ, Pearson RK, Clain JE, Farnell MB, Sarr MG, Chari ST (2004) Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. Clin Gastroenterol Hepatol 2: 1026–1031
Rodriguez JR, Salvia R, Crippa S, Warshaw AL, Bassi C, Falconi M, Thayer SP, Lauwers GY, Capelli P, Mino-Kenudson M, Razo O, McGrath D, Pederzoli P, Fernandez-del Castillo C (2007) Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology 133: 72–79; quiz 309–310
Santini D, Poli F, Lega S (2006) Solid-papillary tumors of the pancreas: histopathology. Jop 7: 131–136
Sarr MG, Carpenter HA, Prabhakar LP, Orchard TF, Hughes S, van Heerden JA, DiMagno EP (2000) Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? Ann Surg 231: 205–212
Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, Lillemoe KD (2004) Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 239: 788–797; discussion 797–789
Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6: 17–32
Tanaka M, Fernandez-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY, Kimura W, Levy P, Pitman MB, Schmidt CM, Shimizu M, Wolfgang CL, Yamaguchi K, Yamao K (2012) International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12: 183–197
Weinberg BM, Spiegel BM, Tomlinson JS, Farrell JJ (2010) Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using Markov-based clinical nomograms. Gastroenterology 138: 531–540
Werner J, Fritz S, Buchler MW (2012) Intraductal papillary mucinous neoplasms of the pancreas – a surgical disease. Nat Rev Gastroenterol Hepatol 9: 253–259
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fritz, S., Werner, J. (2013). Indikationen zur operativen Therapie zystischer Pankreasneoplasien. In: Beger, H., et al. Erkrankungen des Pankreas. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-37964-2_53
Download citation
DOI: https://doi.org/10.1007/978-3-642-37964-2_53
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-37963-5
Online ISBN: 978-3-642-37964-2
eBook Packages: Medicine (German Language)